Correlation of released HMGB1 levels with the degree of islet damage in mice and humans and with the outcomes of islet transplantation in mice

Cell Transplantation

Volumn 21, Issue 7, 2012, Pages 1371-1381

  Itoh, Takeshi ^a   Takita, Morihito ^a   SoRelle, Jeffrey A ^b   Shimoda, Masayuki ^c   Sugimoto, Koji ^a   Chujo, Daisuke ^d   Qin, Huanying ^e   Naziruddin, Bashoo ^c   Levy, Marlon F ^c   Matsumoto, Shinichi ^a  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^e BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

High mobility group box 1 (HMGB1); Hypoxia; Islet; Potency assay; Transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; C PEPTIDE; DNA; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; MOUSE; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY;

ANIMALS; BLOOD GLUCOSE; C-PEPTIDE; CELL HYPOXIA; CELL SEPARATION; DIABETES MELLITUS, EXPERIMENTAL; HMGB1 PROTEIN; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; ROC CURVE;

MUS;

EID: 84868515945     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X640592     Document Type: Article

References (35)

1. Armann, B.; Hanson, M. S.; Hatch, E.; Steffen, A.; Fernandez, L. A. Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am. J. Transplant. 7:38-47; 2007.
2. Barnett, M. J.; McGhee-Wilson, D.; Shapiro, A. M.; Lakey, J. R. Variation in human islet viability based on different membrane integrity stains. Cell Transplant. 13: 481-488; 2004.
3. Eriksson, O.; Eich, T.; Sundin, A.; Tibell, A.; Tufveson, G.; Andersson, H.; Felldin, M.; Foss, A.; Kyllonen, L.; Langstrom, B.; Nilsson, B.; Korsgren, O.; Lundgren, T. Positron emission tomography in clinical islet transplantation. Am. J. Transplant. 9:2816-2824; 2009.
4. Goto, M.; Holgersson, J.; Kumagai-Braesch, M.; Korsgren, O. The ADP/ATP ratio: A novel predictive assay for quality assessment of isolated pancreatic islets. Am. J. Transplant. 6:2483-2487; 2006.
5. Hanson, M. S.; Steffen, A.; Danobeitia, J. S.; Ludwig, B.; Fernandez, L. A. Flow cytometric quantification of glucose-stimulated beta-cell metabolic flux can reveal impaired islet functional potency. Cell Transplant. 17: 1337-1347; 2008.
6. Hatanaka, N.; Takita, M.; Yamaguchi, T.; Kami, M.; Matsumoto, S. Interests in beta-cell replacement therapies among Japanese patients with type 1 diabetes. Diabetes Res. Clin. Pract. 89:e5-8; 2010.
7. Ichii, H.; Inverardi, L.; Pileggi, A.; Molano, R. D.; Cabrera, O.; Caicedo, A.; Messinger, S.; Kuroda, Y.; Berggren, P. O.; Ricordi, C. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am. J. Transplant. 5:1635-1645; 2005.
8. Kim, J. H.; Park, S. G.; Lee, H. N.; Lee, Y. Y.; Park, H. S.; Kim, H. I.; Yu, J. E.; Kim, S. H.; Park, C. G.; Ha, J.; Kim, S. J.; Park, K. S. ATP measurement predicts porcine islet transplantation outcome in nude mice. Transplantation 87:166-169; 2009.
9. Lotze, M. T.; Tracey, K. J. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-342; 2005.
10. Matsumoto, S. Islet cell transplantation for type 1 diabetes. J. Diabetes 2:16-22; 2010.
11. Matsumoto, S.; Noguichi, H.; Shimoda, M.; Ikemoto, T.; Naziruddin, B.; Jackson, A.; Tamura, Y.; Olson, G.; Fujita, Y.; Chujo, D.; Takita, M.; Kobayashi, N.; Onaca, N.; Levy, M. Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant. 19:291-297; 2010.
12. Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Noguci, H.; Nagata, H.; Yonekawa, Y.; Yamada, Y.; Fukuda, K.; Tsukiyama, K.; Suzuki, H.; Kawasaki, Y.; Shimodaira, M.; Matsuoka, K.; Shibata, T.; Kasai, Y.; Maekawa, T.; Shapiro, J.; Tanaka, K. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 365:1642-1644; 2005.
13. 2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 74: 1414-1419; 2002.
14. Matsumoto, S.; Takita, M.; Chaussabel, D.; Noguchi, H.; Shimoda, M.; Sugimoto, K.; Itoh, T.; Chujo, D.; SoRelle, J.; Onaca, N.; Naziruddin, B.; Levy, M. F. Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant. 20:1641-1647; 2011.
15. Matsuoka, N.; Itoh, T.; Watarai, H.; Sekine-Kondo, E.; Nagata, N.; Okamoto, K.; Mera, T.; Yamamoto, H.; Yamada, S.; Maruyama, I.; Taniguchi, M.; Yasunami, Y. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J. Clin. Invest. 120:735-743; 2010.
16. Mohammed, J. S.; Wang, Y.; Harvat, T. A.; Oberholzer, J.; Eddington, D. T. Microfluidic device for multimodal characterization of pancreatic islets. Lab Chip 9:97-106; 2009.
17. Müller, S.; Ronfani, L.; Bianchi, M. E. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J. Intern. Med. 255:332-343; 2004.
18. Noguchi, H.; Ueda, M.; Hayashi, S.; Kobayashi, N.; Okitsu, T.; Iwanaga, Y.; Nagata, H.; Nakai, Y.; Matsumoto, S. Ductal injection of preservation solution increases islet yields in islet isolation and improves islet graft function. Cell Transplant. 17:69-81; 2008.
19. Papas, K. K.; Colton, C. K.; Nelson, R. A.; Rozak, P. R.; Avgoustiniatos, E. S.; Scott, 3rd., W. E.; Wildey, G. M.; Pisania, A.; Weir, G. C.; Hering, B. J. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am. J. Transplant. 7:707-713; 2007.
20. Papas, K. K.; Suszynski, T. M.; Colton, C. K. Islet assessment for transplantation. Curr. Opin. Organ Transplant. 14:674-682; 2009.
21. Ricordi, C. Islet transplantation: A brave new world. Diabetes 52:1595-1603; 2003.
22. Ricordi, C.; Lacy, P. E.; Finke, E. H.; Olack, B. J.; Scharp, D. W. Automated method for isolation of human pancreatic islets. Diabetes 37:413-420; 1988.
23. Sakata, N.; Tan, A.; Chan, N.; Obenaus, A.; Mace, J.; Peverini, R.; Sowers, L.; Chinnock, R.; Hathout, E. Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. Transplant. Proc. 41:346-349; 2009.
24. Saldeen, J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 141:2003-2010; 2000.
25. Seong, S. Y.; Matzinger, P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4:469-478; 2004.
26. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
27. Shapiro, A. M.; Ricordi, C.; Hering, B. J.; Auchincloss, H.; Lindblad, R.; Robertson, R. P.; Secchi, A.; Brendel, M. D.; Berney, T.; Brennan, D. C.; Cagliero, E.; Alejandro, R.; Ryan, E. A.; DiMercurio, B.; Morel, P.; Polonsky, K. S.; Reems, J. A.; Bretzel, R. G.; Bertuzzi, F.; Froud, T.; Kandaswamy, R.; Sutherland, D. E.; Eisenbarth, G.; Segal, M.; Preiksaitis, J.; Korbutt, G. S.; Barton, F. B.; Viviano, L.; Seyfert-Margolis, V.; Bluestone, J.; Lakey, J. R. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355:1318-1330; 2006.
28. Sims, G. P.; Rowe, D. C.; Rietdijk, S. T.; Herbst, R.; Coyle, A. J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28:367-388; 2010.
29. Suszynski, T. M.; Wildey, G. M.; Falde, E. J.; Cline, G. W.; Maynard, K. S.; Ko, N.; Sotiris, J.; Naji, A.; Hering, B. J.; Papas, K. K. The ATP/DNA ratio is a better indicator of islet cell viability than the ADP/ATP ratio. Transplant. Proc. 40:346-350; 2008.
30. Sweet, I. R.; Gilbert, M. Contribution of calcium influx in mediating glucose-stimulated oxygen consumption in pancreatic islets. Diabetes 55:3509-3519; 2006.
31. Sweet, I. R.; Gilbert, M.; Scott, S.; Todorov, I.; Jensen, R.; Nair, I.; Al-Abdullah, I.; Rawson, J.; Kandeel, F.; Ferreri, K. Glucose-stimulated increment in oxygen consumption rate as a standardized test of human islet quality. Am. J. Transplant. 8:183-192; 2008.
32. Tjernberg, J.; Ekdahl, K. N.; Lambris, J. D.; Korsgren, O.; Nilsson, B. Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation 85:1193-1199; 2008.
33. Wang, W.; Upshaw, L.; Strong, D. M.; Robertson, R. P.; Reems, J. Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets. J. Endocrinol. 185:445-455; 2005.
34. Weber, D. J.; McFarland, R. D.; Irony, I. Selected Food and Drug Administration review issues for regulation of allogeneic islets of langerhans as somatic cell therapy. Transplantation 74:1816-1820; 2002.
35. Yamada, S.; Yakabe, K.; Ishii, J.; Imaizumi, H.; Maruyama, I. New high mobility group box 1 assay system. Clin. Chim. Acta 372:173-178; 2006.